Tuesday, October 5, 2021
Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels.
The Gist Healthcare Podcast · Gist Healthcare Daily
October 5, 20216m 50s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels.
Hosted on Acast. See acast.com/privacy for more information.